RAAPID has boosted the Defensible Risk Adjustment program by incorporating Healthworx in its collaborative strategy. With that, a complete industry collaboration is in place. This initiative ensures that defensible risk adjustment is strengthened in all healthcare organizations. It further ensures compliance and accuracy in value-based care settings.
In the said collaboration, Healthworx joins Microsoft and UPMC Enterprises. The idea behind such collaboration is to ensure that there are no issues related to risk adjustment. Healthcare institutions would then be able to achieve coding accuracy. Other than that, they will have better clinical and financial results. RAAPID continues to enhance its Defensible Risk Adjustment programs by means of innovation. RAAPID applies AI-enabled analytics to pinpoint risk factors.
“M12 validated our technology; UPMC Enterprises validated our clinical rigor; and now, Healthworx validates our regulatory strategy,” said Chetan Parikh, CEO and Founder of RAAPID. “Payers are closest to the regulatory fire. When a payer-backed investor like Healthworx puts capital behind your platform, it sends a clear signal: The market is no longer looking for more codes – it is looking for defensible accuracy. RAAPID is the only platform built to survive a CMS audit while delivering a 10:1 operational ROI.”
Strengthening Healthcare Accuracy Through Strategic Collaboration
In addition, the partnership allows the merger of technology skills and healthcare skills. The emphasis is on providing robust solutions that are scalable and dependable. As a result, there are frameworks that are easily adaptable. The initiative also meets the requirements of the industry when it comes to transparency. Indeed, RAAPID is still setting trends in terms of healthcare analytics.
“Healthworx Ventures is dedicated to backing cutting-edge startups that fundamentally reshape healthcare administration and delivery for the long term, and RAAPID is a prime example of that vision,” said Dan Zohorsky, Managing Partner at Healthworx. “By developing novel Neuro-symbolic AI-powered products that make risk adjustment defensible, compliant, and transparent, RAAPID is creating a new standard of accuracy that drives immense value across the entire healthcare ecosystem.”
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
